CADD Infusion Administration Set Recalled for Delivery Failure and False Alarms
Smiths Medical is recalling CADD Administration Sets due to tubing occlusion that can prevent medication delivery and false pump alarms. This FDA Class I recall affects 214,668 units worldwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which per the rubric requires a minimum severity score of 4. No illnesses or injuries are documented in the source text. The classification of Severe reflects the critical role of the affected infusion system in delivering medications.
Plain-English summary
Smiths Medical ASD Inc. is recalling CADD Administration Sets (Reference numbers 21-7600-24, 21-7609-24, 21-7624-24, and 21-7649-24, and their JP variants) due to two potential safety issues affecting the infusion system.
The recalled sets may fail to deliver medication or deliver an insufficient amount due to tubing occlusion (blockage). Additionally, users may receive false 'No Disposable Attached (NDA)' alarm alerts from the infusion pump system. These issues could result in patients not receiving their prescribed medication or receiving incorrect dosages.
The recall affects 214,668 units and has worldwide distribution. Affected lot numbers range from 4072200 through 4334357, with specific lot ranges varying by product reference number.
Patients and healthcare providers should discontinue use of affected sets and contact Smiths Medical for replacement units. Healthcare facilities should verify which lots they have in inventory using the specific lot numbers provided by Smiths Medical.
The recalled product
- Product
- CADD Administration Set, List Numbers: a) REF 21-7600-24, b) REF 21-7609-24, c) REF 21-7624-24, d) REF 21-7649-24, e) REF 21-7600-24JP, f) REF 21-7609-24JP, g) REF 21-7624-24JP, h) REF 21-7649-24JP Computerized Ambulatory Delivery Device
- Manufacturer
- Smiths Medical ASD Inc.
- Affected units
- 214,668
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- a) REF 21-7600-24
- UDI/DI 30610586044001
- Lot Numbers: 4084914 through 4329633
- b) REF 21-7609-24
- UDI/DI 30610586044018
- Lot Numbers: 4072200 through 4334090
- c) REF 21-7624-24
- UDI/DI 30610586044742
- Lot Numbers: 4092506 through 4309481
- d) REF 21-7649-24
- UDI/DI 35019517184246
- Lot Numbers: 4076410 through 4334357
- e) REF 21-7600-24JP
- UDI/DI N/A
- f) REF 21-7609-24JP
- g) REF 21-7624-24JP
- h) REF 21-7649-24JP
- Lot Numbers: 4076410 through 4334357.
Distribution
Part of a larger recall action
This product is one of 5 recalled by Smiths Medical ASD Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Smiths Medical ASD Inc.
See all →- SevereCADD Solis VIP Ambulatory Infusion Pump Thermal Damage Recall
FDA (Devices) · 2025-05-14
- SevereCADD-Solis Infusion Pump Thermal Damage Risk Recall
FDA (Devices) · 2025-05-14
- CriticalCADD Solis HSPCA Pump wireless connection alarm interruption recall
FDA (Devices) · 2025-05-14
- CriticalCADD-Solis Ambulatory Infusion Pump False Alarm Malfunction
FDA (Devices) · 2025-05-14
- CriticalCADD-Solis VIP Ambulatory Infusion Pump False Occlusion Alarm Recall
FDA (Devices) · 2025-05-14
Same hazard · tubing occlusion
See all →- SevereCADD Infusion Administration Sets Recalled for Tubing Occlusion and False Alarms
FDA (Devices) · 2023-02-08
- SevereCADD Administration Sets recall for delivery failure and false alarms
FDA (Devices) · 2023-02-08
- SevereCADD Administration Set recall: medication underdelivery and false alarms
FDA (Devices) · 2023-02-08
- SevereCADD Infusion Administration Sets Recalled for Delivery Failure and Alarms
FDA (Devices) · 2023-02-08